STUDY: Telecovid – Remote Patient Monitoring for COVID-19

Within the framework of a first-in-class study in Munich, cosinuss° provides the pioneering biosensor technology to monitor low and medium risk patients of COVID-19, who are in home isolation. The clinical study is initiated and led by Prof. Dr. Med. Georg Schmidt, head of the Biosignal Analysis Working Group, Klinikum rechts der Isar, Technical University of Munich.